1. Home
  2. ATRA vs VGI Comparison

ATRA vs VGI Comparison

Compare ATRA & VGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRA
  • VGI
  • Stock Information
  • Founded
  • ATRA 2012
  • VGI 2012
  • Country
  • ATRA United States
  • VGI United States
  • Employees
  • ATRA N/A
  • VGI N/A
  • Industry
  • ATRA Biotechnology: Biological Products (No Diagnostic Substances)
  • VGI Investment Managers
  • Sector
  • ATRA Health Care
  • VGI Finance
  • Exchange
  • ATRA Nasdaq
  • VGI Nasdaq
  • Market Cap
  • ATRA 97.0M
  • VGI 88.2M
  • IPO Year
  • ATRA 2014
  • VGI N/A
  • Fundamental
  • Price
  • ATRA $15.21
  • VGI $7.93
  • Analyst Decision
  • ATRA Strong Buy
  • VGI
  • Analyst Count
  • ATRA 3
  • VGI 0
  • Target Price
  • ATRA $21.00
  • VGI N/A
  • AVG Volume (30 Days)
  • ATRA 54.6K
  • VGI 46.0K
  • Earning Date
  • ATRA 11-06-2025
  • VGI 01-01-0001
  • Dividend Yield
  • ATRA N/A
  • VGI 12.66%
  • EPS Growth
  • ATRA N/A
  • VGI N/A
  • EPS
  • ATRA 0.56
  • VGI N/A
  • Revenue
  • ATRA $188,667,000.00
  • VGI N/A
  • Revenue This Year
  • ATRA N/A
  • VGI N/A
  • Revenue Next Year
  • ATRA N/A
  • VGI N/A
  • P/E Ratio
  • ATRA $27.00
  • VGI N/A
  • Revenue Growth
  • ATRA 202.41
  • VGI N/A
  • 52 Week Low
  • ATRA $5.01
  • VGI $6.68
  • 52 Week High
  • ATRA $18.71
  • VGI $7.99
  • Technical
  • Relative Strength Index (RSI)
  • ATRA 55.36
  • VGI 54.24
  • Support Level
  • ATRA $14.14
  • VGI $7.75
  • Resistance Level
  • ATRA $16.15
  • VGI $7.90
  • Average True Range (ATR)
  • ATRA 1.06
  • VGI 0.07
  • MACD
  • ATRA -0.11
  • VGI 0.00
  • Stochastic Oscillator
  • ATRA 44.28
  • VGI 62.07

About ATRA Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

About VGI Virtus Global Multi-Sector Income Fund of Beneficial Interest

Virtus Global Multi-Sector Inc is a United States based fund. Its investment objective is to maximize current income while preserving capital. The Fund seeks to achieve its investment objective by applying extensive credit research to capitalize on opportunities across undervalued areas of the international bond markets.

Share on Social Networks: